Investing
Acquired in-process research and development
Accenture Acquired in-process research and development remained flat by 0.0% to $204.33M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 29.0%, from $287.61M to $204.33M. Over 4 years (FY 2021 to FY 2025), Acquired in-process research and development shows a downward trend with a -7.5% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryGrowth
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ4 2025Oct 10, 2025
How to read this metric
High spending indicates a strong commitment to pipeline growth, though it carries significant execution and regulatory risk.
Detailed definition
This represents the cash outflow for the acquisition of in-process research and development projects from other entities...
Peer comparison
High in the pharmaceutical industry where external innovation is a primary driver of long-term revenue.
Metric ID:
acquired_ipr_dHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.12B | $1.12B | $1.30B | $1.15B | $817.30M |
| YoY Change | — | +0.4% | +15.6% | -11.4% | -29.0% |
Range$817.30M – $1.30B
CAGR-7.5%
Avg YoY Growth-6.1%
Median YoY Growth-5.5%
Current Streak2 years decline
Acquired in-process research and development at Other Companies
Frequently Asked Questions
- What is Accenture's acquired in-process research and development?
- Accenture (ACN) reported acquired in-process research and development of $204.33M in Q2 2025.
- How has Accenture's acquired in-process research and development changed year-over-year?
- Accenture's acquired in-process research and development decreased by 29.0% year-over-year, from $287.61M to $204.33M.
- What is the long-term trend for Accenture's acquired in-process research and development?
- Over 4 years (2021 to 2025), Accenture's acquired in-process research and development has grown at a -7.5% compound annual growth rate (CAGR), from $1.12B to $817.30M.
- What does acquired in-process research and development mean?
- Cash spent to acquire research projects or drug candidates currently in development.